Evidence map›Paper›PMID 35284627›Full record

ArticleMolecular therapy oncolytics2022

A host non-coding RNA, nc886, plays a pro-viral role by promoting virus trafficking to the nucleus.

Enkhjin Saruuldalai, Jiyoung Park, Dongmin Kang, Seung-Phil Shin, Wonkyun Ronny Im, Hwi-Ho Lee, Jiyoung Joan Jang, Jong-Lyul Park, Seon-Young Kim, Jung-Ah Hwang and 7 more

Open access · goldAbstract read
In one paragraph

Article in Molecular therapy oncolytics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Non-coding 886 (Epigenetics · 2024
    Review
  4. The small noncoding RNARNA (New York, N.Y.) · 2024
    Article
  5. Review
  6. Article
  7. Review
  8. Hypermethylation ofMolecular therapy. Nucleic acids · 2022
    Article
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Enkhjin SaruuldalaiDepartment of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang 10408, Korea.
Jiyoung ParkFluorescence Core Imaging Center, Department of Life Science, Ewha Womans University, Seoul 03760, Korea.
Dongmin KangFluorescence Core Imaging Center, Department of Life Science, Ewha Womans University, Seoul 03760, Korea.
Seung-Phil ShinDivision of Cancer Immunology, Research Institute, National Cancer Center, Goyang 10408, Korea.
Wonkyun Ronny ImDepartment of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang 10408, Korea.
Hwi-Ho LeeDepartment of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang 10408, Korea.
Jiyoung Joan JangDepartment of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang 10408, Korea.
Jong-Lyul ParkPersonalized Genomic Medicine Research Center, KRIBB, Daejeon 34141, Korea.
Seon-Young KimPersonalized Genomic Medicine Research Center, KRIBB, Daejeon 34141, Korea.
Jung-Ah HwangGenomics Core Facility, Research Core Center, Research Institute, National Cancer Center, Goyang 10408, Korea.
Young-Dong KimDepartment of Life Science, Hallym University, Chuncheon 24252, Korea.
Jung-Hoon LeeMultidisciplinary Genome Institute, Hallym University, Chuncheon 24252, Korea.
Eun Jung ParkDepartment of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang 10408, Korea.
Yeon-Su LeeDivision of Clinical Cancer Research, Research Institute, National Cancer Center, Goyang 10408, Korea.
In-Hoo KimDepartment of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang 10408, Korea.
Sang-Jin LeeDivision of Cancer Immunology, Research Institute, National Cancer Center, Goyang 10408, Korea.
Yong Sun LeeDepartment of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang 10408, Korea.
National Cancer Center · KREwha Womans University · KRHallym University · KRKorea Research Institute of Bioscience and Biotechnology · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Elucidation of the interplay between viruses and host cells is crucial for taming viruses to benefit human health. Cancer therapy using adenovirus, called oncolytic virotherapy, is a promising treatment option but is not robust in all patients. In addition, inefficient replication of human adenovirus in mouse hampered the development of an

Indexed as

adenovirushost tropismkinesinnc886non-coding RNAoncolytic virotherapyProtein Kinase R

Identifiers

PMID35284627
PMCPMC8904404
OpenAlexW4212831998

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.